AU Stock MarketDetailed Quotes

CU6 Clarity Pharmaceuticals Ltd

Watchlist
  • 7.140
  • +0.060+0.85%
20min DelayMarket Closed Nov 15 16:00 AET
2.29BMarket Cap-46064P/E (Static)

Clarity Pharmaceuticals Ltd Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(FY)Jun 30, 2022
(Q4)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
109.96%136.51M
109.96%136.51M
-29.59%65.01M
-29.59%65.01M
--92.34M
--92.34M
-Cash and cash equivalents
53.46%47.9M
53.46%47.9M
-43.59%31.21M
-43.59%31.21M
--55.34M
--55.34M
-Short term investments
162.13%88.6M
162.13%88.6M
-8.64%33.8M
-8.64%33.8M
--37M
--37M
Receivables
26.32%12.63M
26.32%12.63M
50.24%10M
50.24%10M
--6.66M
--6.66M
-Other receivables
26.32%12.63M
26.32%12.63M
50.24%10M
50.24%10M
--6.66M
--6.66M
Prepaid assets
196.31%4.92M
196.31%4.92M
198.59%1.66M
198.59%1.66M
--556.21K
--556.21K
Total current assets
100.92%154.06M
100.92%154.06M
-22.98%76.68M
-22.98%76.68M
--99.55M
--99.55M
Non current assets
Net PPE
169.14%554.8K
169.14%554.8K
-20.74%206.14K
-20.74%206.14K
--260.09K
--260.09K
-Gross PPE
113.23%929.43K
113.23%929.43K
11.96%435.89K
11.96%435.89K
--389.32K
--389.32K
-Accumulated depreciation
-63.07%-374.63K
-63.07%-374.63K
-77.78%-229.74K
-77.78%-229.74K
---129.23K
---129.23K
Investments and advances
5.53%13.03K
5.53%13.03K
5.09%12.34K
5.09%12.34K
--11.75K
--11.75K
-Other investment
5.53%13.03K
5.53%13.03K
5.09%12.34K
5.09%12.34K
--11.75K
--11.75K
Total non current assets
159.89%567.83K
159.89%567.83K
-19.63%218.49K
-19.63%218.49K
--271.84K
--271.84K
Total assets
101.09%154.63M
101.09%154.63M
-22.97%76.9M
-22.97%76.9M
--99.82M
--99.82M
Liabilities
Current liabilities
Payables
3.25%6.96M
3.25%6.96M
-0.78%6.74M
-0.78%6.74M
--6.79M
--6.79M
-accounts payable
-26.77%2.08M
-26.77%2.08M
-0.11%2.85M
-0.11%2.85M
--2.85M
--2.85M
-Other payable
25.20%4.87M
25.20%4.87M
-1.26%3.89M
-1.26%3.89M
--3.94M
--3.94M
Pension and other retirement benefit plans
40.85%1.13M
40.85%1.13M
12.42%802.61K
12.42%802.61K
--713.93K
--713.93K
Other current liabilities
----
----
---1
---1
----
----
Current liabilities
7.25%8.09M
7.25%8.09M
0.48%7.54M
0.48%7.54M
--7.51M
--7.51M
Non current liabilities
Employee benefits
35.91%242.87K
35.91%242.87K
125.55%178.7K
125.55%178.7K
--79.23K
--79.23K
Total non current liabilities
35.91%242.87K
35.91%242.87K
125.55%178.7K
125.55%178.7K
--79.23K
--79.23K
Total liabilities
7.91%8.33M
7.91%8.33M
1.78%7.72M
1.78%7.72M
--7.59M
--7.59M
Shareholders'equity
Share capital
87.81%249.45M
87.81%249.45M
0.53%132.82M
0.53%132.82M
--132.12M
--132.12M
-common stock
87.81%249.45M
87.81%249.45M
0.53%132.82M
0.53%132.82M
--132.12M
--132.12M
Retained earnings
-60.14%-112.7M
-60.14%-112.7M
-53.67%-70.37M
-53.67%-70.37M
---45.8M
---45.8M
Gains losses not affecting retained earnings
41.89%9.55M
41.89%9.55M
13.74%6.73M
13.74%6.73M
--5.92M
--5.92M
Total stockholders'equity
111.49%146.3M
111.49%146.3M
-25.00%69.18M
-25.00%69.18M
--92.24M
--92.24M
Total equity
111.49%146.3M
111.49%146.3M
-25.00%69.18M
-25.00%69.18M
--92.24M
--92.24M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2024(Q4)Jun 30, 2024(FY)Jun 30, 2023(Q4)Jun 30, 2023(FY)Jun 30, 2022(Q4)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 109.96%136.51M109.96%136.51M-29.59%65.01M-29.59%65.01M--92.34M--92.34M
-Cash and cash equivalents 53.46%47.9M53.46%47.9M-43.59%31.21M-43.59%31.21M--55.34M--55.34M
-Short term investments 162.13%88.6M162.13%88.6M-8.64%33.8M-8.64%33.8M--37M--37M
Receivables 26.32%12.63M26.32%12.63M50.24%10M50.24%10M--6.66M--6.66M
-Other receivables 26.32%12.63M26.32%12.63M50.24%10M50.24%10M--6.66M--6.66M
Prepaid assets 196.31%4.92M196.31%4.92M198.59%1.66M198.59%1.66M--556.21K--556.21K
Total current assets 100.92%154.06M100.92%154.06M-22.98%76.68M-22.98%76.68M--99.55M--99.55M
Non current assets
Net PPE 169.14%554.8K169.14%554.8K-20.74%206.14K-20.74%206.14K--260.09K--260.09K
-Gross PPE 113.23%929.43K113.23%929.43K11.96%435.89K11.96%435.89K--389.32K--389.32K
-Accumulated depreciation -63.07%-374.63K-63.07%-374.63K-77.78%-229.74K-77.78%-229.74K---129.23K---129.23K
Investments and advances 5.53%13.03K5.53%13.03K5.09%12.34K5.09%12.34K--11.75K--11.75K
-Other investment 5.53%13.03K5.53%13.03K5.09%12.34K5.09%12.34K--11.75K--11.75K
Total non current assets 159.89%567.83K159.89%567.83K-19.63%218.49K-19.63%218.49K--271.84K--271.84K
Total assets 101.09%154.63M101.09%154.63M-22.97%76.9M-22.97%76.9M--99.82M--99.82M
Liabilities
Current liabilities
Payables 3.25%6.96M3.25%6.96M-0.78%6.74M-0.78%6.74M--6.79M--6.79M
-accounts payable -26.77%2.08M-26.77%2.08M-0.11%2.85M-0.11%2.85M--2.85M--2.85M
-Other payable 25.20%4.87M25.20%4.87M-1.26%3.89M-1.26%3.89M--3.94M--3.94M
Pension and other retirement benefit plans 40.85%1.13M40.85%1.13M12.42%802.61K12.42%802.61K--713.93K--713.93K
Other current liabilities -----------1---1--------
Current liabilities 7.25%8.09M7.25%8.09M0.48%7.54M0.48%7.54M--7.51M--7.51M
Non current liabilities
Employee benefits 35.91%242.87K35.91%242.87K125.55%178.7K125.55%178.7K--79.23K--79.23K
Total non current liabilities 35.91%242.87K35.91%242.87K125.55%178.7K125.55%178.7K--79.23K--79.23K
Total liabilities 7.91%8.33M7.91%8.33M1.78%7.72M1.78%7.72M--7.59M--7.59M
Shareholders'equity
Share capital 87.81%249.45M87.81%249.45M0.53%132.82M0.53%132.82M--132.12M--132.12M
-common stock 87.81%249.45M87.81%249.45M0.53%132.82M0.53%132.82M--132.12M--132.12M
Retained earnings -60.14%-112.7M-60.14%-112.7M-53.67%-70.37M-53.67%-70.37M---45.8M---45.8M
Gains losses not affecting retained earnings 41.89%9.55M41.89%9.55M13.74%6.73M13.74%6.73M--5.92M--5.92M
Total stockholders'equity 111.49%146.3M111.49%146.3M-25.00%69.18M-25.00%69.18M--92.24M--92.24M
Total equity 111.49%146.3M111.49%146.3M-25.00%69.18M-25.00%69.18M--92.24M--92.24M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg

No Data